PARADIGM CAPITAL MANAGEMENT INC/NY Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$2.1T

Holdings

122

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (122 positions)

#StockSharesValue% PortfolioType
101
HALOHalozyme Therapeutics, Inc.
10,000$520.2M0.03%
102
ICHRIchor Holdings
26,000$510.6M0.02%
103
HIHillenbrand Inc
23,300$467.6M0.02%
104
QA4AGentherm Inc
15,000$424.4M0.02%
105
PGProcter & Gamble
2,500$398.3M0.02%
106
PRIMPrimoris Services Corp
5,000$389.7M0.02%
107
TELATELA Bio, Inc.
200,000$388.0M0.02%
108
FW2NBanner Corp New
6,000$384.9M0.02%
109
AMATApplied Materials
2,000$366.1M0.02%
110
EWEdwards Lifesciences Corporation
4,400$344.1M0.02%
111
NBHCNational Bank Hldgs Corp Cl A
9,000$338.5M0.02%
112
FNFFidelity National Financial
5,900$330.8M0.02%
113
PFEPfizer, Inc
11,400$276.3M0.01%
114
NVMINova Measuring Instruments Ltd
1,000$275.2M0.01%
115
JXC1Ziff-Davis Inc
8,350$252.8M0.01%
116
NEOGNeogen Corporation
52,000$248.6M0.01%
117
HROWHarrow Inc.
8,000$244.3M0.01%
118
BMYBristol-Myers Squibb
5,100$236.1M0.01%
119
CMBMCambium Networks Corporation
466,900$189.1M0.01%
120
LAKELakeland Industies, Inc.
10,000$136.1M0.01%
121
CDXSCodexis, Inc.
50,000$122.0M0.01%
122
FLBStandard BioTools Inc.
17,457$20.9M0.00%
PreviousPage 2 of 2